Compare ETON & ESRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETON | ESRT |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.7M | 913.4M |
| IPO Year | 2018 | 2012 |
| Metric | ETON | ESRT |
|---|---|---|
| Price | $28.42 | $5.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $39.33 | $6.35 |
| AVG Volume (30 Days) | 380.3K | ★ 1.4M |
| Earning Date | 05-14-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.49% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.05 | 0.01 |
| Revenue | $79,950,000.00 | ★ $768,270,000.00 |
| Revenue This Year | $40.90 | $4.26 |
| Revenue Next Year | $47.23 | $1.52 |
| P/E Ratio | $552.20 | ★ $538.00 |
| Revenue Growth | ★ 104.94 | 0.05 |
| 52 Week Low | $13.09 | $4.87 |
| 52 Week High | $35.66 | $8.76 |
| Indicator | ETON | ESRT |
|---|---|---|
| Relative Strength Index (RSI) | 46.69 | 45.61 |
| Support Level | $28.00 | $5.32 |
| Resistance Level | $32.31 | $5.83 |
| Average True Range (ATR) | 1.96 | 0.15 |
| MACD | -0.80 | -0.02 |
| Stochastic Oscillator | 19.55 | 27.19 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.